Format

Send to

Choose Destination
N Engl J Med. 2020 Feb 6;382(6):586. doi: 10.1056/NEJMx190033.

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.

[No authors listed]
PMID:
32023396
DOI:
10.1056/NEJMx190033

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center